Spero Therapeutics issues 102,000 RSUs, 67,600 options to new hires under inducement plan
SPRO•Inducement equity awards granted to new hires
Spero Therapeutics granted 102,000 RSUs and 67,600 stock options to new employees under its 2019 Inducement Equity Incentive Plan.
- The awards were granted on Sept. 1, 2026.
- The stock options vest 25% on Sept. 1, 2027, then in 36 equal monthly installments, contingent on continued employment.
- The RSUs vest in four equal annual installments starting Sept. 1, 2027, contingent on continued employment.
